Pharmaceutical Technology15d
NaQuinate by Haoma Medica for Osteoporosis: Likelihood of Approval
NaQuinate is under clinical development by Haoma Medica and currently in Phase I for Osteoporosis. According to GlobalData, Phase I drugs for Osteoporosis have a 65% phase transition success rate ...